Association of liver stiffness and steatosis with hepatocellular carcinoma development in patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.
Toshifumi TadaTakashi NishimuraTomomitsu MatonoMasahiro YoshidaMinako YuriAoi FujiwaraYukihisa YuriTomoyuki TakashimaNobuhiro AizawaNaoto IkedaHirayuki EnomotoTakashi KumadaHiroko IijimaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2021)
A high TE value was a risk factor for HCC in hepatitis C virus patients who received direct-acting antiviral therapy and achieved sustained virological response.